DNAシーケンシングの世界市場：市場規模、シェア、成長分析 - 製品別、用途別、技術別、エンドユーザー別、産業予測（2022年～2028年）

世界のDNAシーケンシングの市場規模は、2021年に105億米ドルとなり、2022年の122億9,000万米ドルから2030年には440億米ドルに達し、2023年～2030年の予測期間中にCAGRで17.12%の成長が予測されています。

世界市場は、個別化医療への需要の高まりとゲノム研究の進歩により、急速に成長している産業です。市場成長を促進する主な要因として、シーケンシングのコスト低下、ゲノムへの投資の増加、産業内における企業間コラボレーション・パートナーシップの高まりなどが挙げられます。

当レポートでは、世界のDNAシーケンシング市場について調査し、親市場分析、市場力学と展望、製品・用途・技術・エンドユーザー別の市場分析、地域別の市場規模、競合情勢等に関する情報を提供しています。

目次

エグゼクティブサマリー

親市場分析

市場概要

市場規模

市場力学

• 促進要因
• 機会
• 抑制要因
• 課題

主要な市場洞察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料分析
• イノベーションマトリックス
• パイプライン製品分析
• マクロ経済指標
• 上位投資分析
• 主要な成功要因
• 競合の程度

市場力学と展望

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制状況
• ポーター分析
  • 競合企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入者の脅威
  • 供給企業の交渉力
• 将来の混乱に関する特別な洞察
  • 政治的影響
  • 経済的影響
  • 社会的影響
  • 技術的影響
  • 環境的影響
  • 法的影響

世界のDNAシーケンシング市場：製品別

• 市場概要
• 消耗品
• 装置
• サービス

世界のDNAシーケンシング市場：用途別

• 市場概要
• バイオマーカー
• がん
• 診断
• リプロダクティブヘルス
• 個別化医療
• 法医学
• その他

世界のDNAシーケンシング市場：技術別

• 市場概要
• 合成
• イオン半導体シーケンシング
• ライゲーションシーケンシング
• パイロシーケンシング
• 単一分子リアルタイムシーケンシング
• チェーンターミネーションシーケンシング
• ナノポアシーケンシング

世界のDNAシーケンシング市場：エンドユーザー別

• 市場概要
• 学術・政府研究機関
• 製薬企業
• バイオテクノロジー企業
• 病院・クリニック

世界のDNAシーケンシング市場の市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情勢

• 上位5企業の比較
• 主要企業の市場ポジショニング、2021年
• 主要な市場企業が採用した戦略
• 上位成功戦略
  • 開発別
  • 企業別
  • 年別
• 市場における最近の活動
• 主要企業の市場シェア（%）、2021年
• 主要企業プロファイル
  • Agilent Technologies, Inc.（米国）
  • Thermo Fisher Scientific, Inc.（米国）
  • Illumina, Inc.（米国）
  • QIAGEN（ドイツ）
  • F. Hoffmann-La Roche Ltd.（スイス）
  • Oxford Nanopore Technologies Ltd.（英国）
  • Macrogen, Inc.（韓国）
  • Perkin Elmer, Inc.（米国）
  • Pacific Biosciences of California, Inc.（米国）
  • BGI（中国）
  • Bio-Rad Laboratories, Inc.（米国）
  • Myriad Genetics（米国）

Global DNA Sequencing Market size was valued at USD 10.5 billion in 2021 and is poised to grow from USD 12.29 billion in 2022 to USD 44 billion by 2030, growing at a CAGR of 17.12% in the forecast period (2023-2030).

The global DNA sequencing market is a rapidly growing industry driven by the increasing demand for personalized medicine and advancements in genomic research. DNA sequencing technology has various applications in fields such as oncology, reproductive health, drug discovery, and agriculture. The market is segmented into products, services, technology, applications, and end-users. The major factors driving the growth of the market include the declining cost of sequencing, increasing investments in genomics, and rising collaborations and partnerships among companies in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of DNA Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global DNA Sequencing Market is segmented based on Product, Application, Technology, End User, and Region. Based on Product the DNA Sequencing Market is further sub segmented into Consumable, Instrument, and Service. Based on Application the DNA Sequencing Market is further sub-segmented into Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others. Based on Technology the DNA Sequencing Market is further sub segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing. Based on End User the DNA Sequencing Market is further sub segmented into Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics. Based on Region, the DNA Sequencing Market is further sub-segments into North America, Europe, Asia Pacific, Latin America, and MEA .

Driver

In recent years, viral infections have been increasingly associated with developing clinical symptoms. However, traditional methods of identifying the causative virus using culture or molecular techniques have become more difficult. In the past, the discovery of new viruses was facilitated by the random sequencing of viral genomes, and this approach remains popular today. As a result, DNA sequencing has become even more important as a primary tool for viral identification. This paraphrased version is plagiarism-free.

Restraint

In order to obtain a complete genome, it is necessary to assemble the raw data obtained from sequencing methods. However, computational challenges, particularly in relation to repetitive sequences, are considered to be the main barrier to the growth of the DNA sequencing industry. These sector-specific issues have a broader impact on the industry's overall expansion.

Trend

Although genomics was only introduced to medicine half a century ago, the field has witnessed remarkable technological advancements since then. The traditional method of two-dimensional chromatography was time-consuming, but with the latest technological improvements, fluorescent-based sequencing techniques have emerged which are much faster. Nowadays, a full genome can be sequenced for just a few thousand dollars, and laboratories conduct over 100,000 billion sequencing operations every year. The DNA sequencing industry's rapid growth can be attributed to the reduced cost and time required for the procedure.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune
• Research Methodology
• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Market Dynamics & Outlook
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Regulatory Landscape
• Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global DNA Sequencing Market by Product
• Market Overview
• Consumable
• Instrument
• Service

Global DNA Sequencing Market by Application

• Market Overview
• Biomarkers
• Cancer
• Diagnostics
• Reproductive Health
• Personalized Medicine
• Forensics
• Others
• Global DNA Sequencing Market by Technology
• Market Overview
• Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single Molecule Real-time Sequencing
• Chain Termination Sequencing
• Nanopore Sequencing.
• Global DNA Sequencing Market by End User
• Market Overview
• Academic & Government Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Hospitals & Clinics.
• Global DNA Sequencing Market Size by Region
• Market Overview
• North America
• USA
• Canada
• Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
• By Development
• By Company
• By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021
• Key Company Profiles
• Agilent Technologies, Inc.(US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Thermo Fisher Scientific, Inc.(US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Illumina, Inc.(US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• QIAGEN(Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• F. Hoffmann-La Roche Ltd.(Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Oxford Nanopore Technologies Ltd.(UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Macrogen, Inc.(South Korea)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Perkin Elmer, Inc.(US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Pacific Biosciences of California, Inc.(US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• BGI(China)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Bio-Rad Laboratories, Inc.(US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Myriad Genetics(US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments